Investing

Goldcorp, Spark Therapeutics Tumble into Monday's 52-Week Low Club

December 11, 2017: Here are four stocks trading with heavy volume among 75 equities making new 52-week lows in Monday’s session. On the NYSE advancers led decliners by about 8 to 7 and on the Nasdaq, decliners led advancers by about the same ratio.

Spark Therapeutics Inc. (NASDAQ: ONCE) dropped 44% Monday to post a new 52-week low of $41.06 after closing at $73.38 on Friday. The 52-week high is $91.75. Volume was around 13.5 million, nearly 30 times the daily average of about 480,000. The company’s hemophilia A drug posted disappointing trial results.

Sprint Corp. (NYSE: S) matched a 52-week low of $5.42 Monday, down 0.3% after closing at $5.44 on Friday. The 52-week high is $9.65. Volume was about 6.8 million, nearly 40% below the daily average of around 16.9 million shares. The company had no specific news.

Goldcorp Inc. (NYSE: GG) dropped about 1.5% Monday to post a new 52-week low of $11.78 after closing at $11.96 on Friday. The 52-week high is $17.87. Volume was around 6.2 million, about equal to the daily average of around 6.4 million. The gold mining company had no specific news.

Syros Pharmaceuticals Inc. (NASDAQ: SYRS) dropped about 49% Monday to post a new 52-week low of $6.30 after closing at $12.37 on Friday. The stock’s 52-week high is $24.38. Volume of around 4.5 million was more than 20 times the daily average. The company’s leading new drug candidate posted disappointing trial results this morning.

Take This Retirement Quiz To Get Matched With An Advisor Now (Sponsored)

Are you ready for retirement? Planning for retirement can be overwhelming, that’s why it could be a good idea to speak to a fiduciary financial advisor about your goals today.

Start by taking this retirement quiz right here from SmartAsset that will match you with up to 3 financial advisors that serve your area and beyond in 5 minutes. Smart Asset is now matching over 50,000 people a month.

Click here now to get started.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.